Aerovate Therapeutics, Inc.
NASDAQ:AVTE
1.98 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||||||
| Current Assets: | ||||||||||||||||
| Cash & Cash Equivalents
| 31.069 | 9.122 | 23.491 | 32.18 | 60.901 | 26.571 | 22.397 | 22.419 | 27.457 | 28.137 | 54.197 | 180.878 | 59.15 | 8.641 | 4.573 | -3.514 |
| Short Term Investments
| 73.133 | 90.212 | 98.948 | 103.019 | 89.195 | 92.358 | 106.823 | 120.159 | 124.531 | 132.935 | 113.178 | 0 | 0 | 0 | 0 | 7.028 |
| Cash and Short Term Investments
| 104.202 | 99.334 | 122.439 | 135.199 | 150.096 | 118.929 | 129.22 | 142.578 | 151.988 | 161.072 | 167.375 | 180.878 | 59.15 | 8.641 | 4.573 | 3.514 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 6.558 | 3.905 | 1.793 | 0.567 | 2.374 | 0.266 | 0.295 | 0.331 | 0.226 | 0.289 | 0.24 | 2.224 | 0.159 | 0.963 | 0.103 | 0 |
| Total Current Assets
| 110.76 | 103.239 | 124.232 | 137.603 | 152.47 | 120.569 | 131.496 | 145.156 | 153.449 | 165.885 | 174.333 | 183.102 | 59.309 | 9.604 | 4.676 | 3.514 |
| Non-Current Assets: | ||||||||||||||||
| Property, Plant & Equipment, Net
| 0.853 | 0.985 | 0.902 | 1.029 | 1.056 | 1.175 | 1.245 | 1.424 | 1.504 | 0.787 | 0.728 | 0.745 | 0.035 | 0.037 | 0.039 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.081 | 2.597 | 2.284 | 2.244 | 2.229 | 2.649 | 2.56 | 1.076 | 0.731 | 0.327 | 0.302 | 0.278 | 3.09 | 0.307 | 0 | -3.514 |
| Total Non-Current Assets
| 0.934 | 3.582 | 3.186 | 3.273 | 3.285 | 3.824 | 3.805 | 2.5 | 2.235 | 1.114 | 1.03 | 1.023 | 3.125 | 0.344 | 0.039 | -3.514 |
| Total Assets
| 111.694 | 106.821 | 127.418 | 140.876 | 155.755 | 124.393 | 135.301 | 147.656 | 155.684 | 166.999 | 175.363 | 184.125 | 62.434 | 9.948 | 4.715 | 0 |
| Liabilities & Equity: | ||||||||||||||||
| Current Liabilities: | ||||||||||||||||
| Account Payables
| 4.179 | 3.313 | 2.396 | 3.504 | 5.529 | 4.726 | 2.575 | 4.541 | 2.068 | 2.863 | 1.208 | 2.555 | 3.042 | 1.55 | 0.618 | 0 |
| Short Term Debt
| 0.475 | 0.445 | 0.42 | 0.451 | 0.379 | 0.373 | 0.385 | 0.379 | 0.347 | 0.193 | 0.192 | 0.147 | 0 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 10.331 | 6.793 | 0 | 0 | 0 | 0 | 0 | 1.007 | 0.943 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 12.366 | 11.76 | 14.821 | 0.439 | 0.583 | 5.538 | 4.822 | 2.785 | 1.341 | 1.647 | 0.143 | 0.18 | 1.151 | 0.232 | 1.156 | 0 |
| Total Current Liabilities
| 17.02 | 15.518 | 17.637 | 14.725 | 13.284 | 10.637 | 7.782 | 7.705 | 3.756 | 4.703 | 2.55 | 3.825 | 4.193 | 1.782 | 1.774 | 0 |
| Non-Current Liabilities: | ||||||||||||||||
| Long Term Debt
| 0.206 | 0.329 | 0.255 | 0.358 | 0.476 | 0.591 | 0.705 | 0.8 | 0.862 | 0.335 | 0.382 | 0.452 | 0 | 0 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.07 | 0.07 | 0.07 | 0.07 | 0.069 | 0.07 | 0.071 | 0.013 | 0.013 | 0.014 | 0.013 | 0 | 79.819 | 24.281 | 16.285 | 0 |
| Total Non-Current Liabilities
| 0.276 | 0.399 | 0.325 | 0.428 | 0.545 | 0.661 | 0.776 | 0.813 | 0.875 | 0.349 | 0.395 | 0.452 | 79.819 | 24.281 | 16.285 | 0 |
| Total Liabilities
| 17.296 | 15.917 | 17.962 | 15.153 | 13.829 | 11.298 | 8.558 | 8.518 | 4.631 | 5.052 | 2.945 | 4.277 | 84.012 | 26.063 | 18.059 | 0 |
| Equity: | ||||||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 184.125 | 62.434 | 24.281 | 16.285 | 4 |
| Common Stock
| 0.003 | 0.003 | 0.003 | 0.003 | 0.003 | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0.002 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -211.385 | -186.61 | -163.424 | -143.011 | -123.448 | -104.423 | -87.903 | -72.881 | -59.293 | -47.302 | -36.392 | -28.169 | -21.985 | -16.201 | -13.407 | 0 |
| Accumulated Other Comprehensive Income/Loss
| -0.083 | -0.033 | 0.237 | -0.195 | -0.223 | -0.201 | -0.466 | -0.771 | -0.785 | -0.644 | -0.059 | -184.125 | 0 | 0 | 0 | -3.643 |
| Other Total Stockholders Equity
| 305.863 | 277.544 | 272.64 | 268.926 | 265.594 | 217.717 | 215.11 | 212.788 | 211.129 | 209.891 | 208.867 | 208.015 | -62.027 | -24.195 | -16.222 | 0 |
| Total Shareholders Equity
| 94.398 | 90.904 | 109.456 | 125.723 | 141.926 | 113.095 | 126.743 | 139.138 | 151.053 | 161.947 | 172.418 | 179.848 | -21.578 | -16.115 | -13.344 | 0.357 |
| Total Equity
| 94.398 | 90.904 | 109.456 | 125.723 | 141.926 | 113.095 | 126.743 | 139.138 | 151.053 | 161.947 | 172.418 | 179.848 | -21.578 | -16.115 | -13.344 | 0.357 |
| Total Liabilities & Shareholders Equity
| 111.694 | 106.821 | 127.418 | 140.876 | 155.755 | 124.393 | 135.301 | 147.656 | 155.684 | 166.999 | 175.363 | 184.125 | 62.434 | 9.948 | 4.715 | 0.357 |